Lyra Therapeutics CEO Maria Palasis' 2021 pay falls 59% to $1.8M
Lyra Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Lyra Therapeutics reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, four executives at Lyra Therapeutics received on average a compensation package of $1M, a 46% decrease compared to previous year.
Average pay of disclosed executives at Lyra Therapeutics
Maria Palasis, Chief Executive Officer, received $1.8M in total, which decreased by 59% compared to 2020. 52% of Palasis' compensation, or $906K, was in option awards. Palasis also received $287K in non-equity incentive plan, $552K in salary, as well as $8.7K in other compensation.
R. Don Elsey, Chief Financial Officer, received a compensation package of $829K, which increased by 9% compared to previous year. 42% of the compensation package, or $351K, was in salary.
Jason Cavalier, Chief Financial Officer, earned $783K in 2021.
Corinne Noyes, Senior Vice President of Commercial Strategy and Market Development, received $653K in 2021.
Related executives
You may also like
Source: SEC filing on April 27, 2022.